# Folate and global health umbrella review series, part 2: syntheses on cancers

**Authors:** Samantha Yoo, Azita Montazeri, Derrick Bennett, Yacong Bo, Peizhan Chen, Susan Duthie, Natalie Jensen, Atipatsa Kaminga, Jun-Shi Lai, Xue Li, Amanda J MacFarlane, Homero Martinez, Helene McNulty, Franco Momoli, Peter Mossey, Patrick Mullie, Ron Munger, Rajendra Prasad Parajuli, Monique Potvin Kent, Michele Rubini, Marjanne Senekal, Lindsey Sikora, Alain Stintzi, Evropi Theodoratou, Hui Wang, Chittaranjan Yajnik, Ann Yaktine, Julian Little

PMC · DOI: 10.7189/jogh.16.04102 · Journal of Global Health · 2026-02-20

## TL;DR

This review examines how folate levels relate to cancer risk, finding some strong links but overall limited evidence.

## Contribution

The study provides a comprehensive umbrella review of folate's associations with various cancers, highlighting credibility levels of findings.

## Key findings

- Highly suggestive links were found for oesophageal, colorectal, and total cancers.
- Evidence for prostate cancer shows a positive signal but needs more research.
- Most associations had limited evidence, with only a few showing strong credibility.

## Abstract

Folate has been examined extensively in relation to carcinogenesis due to its role in one-carbon metabolism impacting the synthesis of DNA and RNA, methylation processes, and genomic integrity. Current evidence on the relationship between folate status and the risk of cancer is equivocal: low or deficient folate status may contribute to an increased risk of cancers, while high-dose folic acid supplementation may have adverse effects on carcinogenesis.

We searched MEDLINE, Embase, CINAHL, the Cochrane Library, and the Database of Abstracts of Reviews of Effects up to February 2024 for systematic reviews and meta-analyses investigating the associations of folate (measured as dietary intake, supplementation, or blood concentrations) with any specific cancer outcome. Screening, data extraction, and risk of bias assessment were performed in duplicate. We assessed the credibility of the evidence using predefined criteria.

We found 67 syntheses, of which 57 provided meta-analyses. Over half of the syntheses had a high risk of bias. We identified 168 unique associations (unique exposure – unique outcome – unique setting) across 10 cancer types, 3 system cancers, and total cancer. Of these, we assessed 15 directional associations (colorectal, oesophageal, and total cancers) to be at a highly suggestive level of credibility, and 17 directional and 10 null associations to be at a suggestive level of credibility.

The available evidence for each category of unique association was generally limited. Highly suggestive associations were found for oesophageal, colorectal, childhood brain and spinal tumours and total cancers. More robust primary studies are warranted to follow-up the signal of a positive relationship reported for prostate cancer warranting further research. Evidence was weak for all but colorectal and oesophageal cancers, or the central nervous system cancers in children.

PROSPERO: CRD42021265041.

## Linked entities

- **Chemicals:** folic acid (PubChem CID 135398658)
- **Diseases:** cancer (MONDO:0004992), colorectal cancer (MONDO:0005575), prostate cancer (MONDO:0005159)

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** ESCC (MESH:D004938), neuroblastoma (MESH:D009447), laryngeal cancer (MESH:D007822), LS (MESH:D007888), dyspepsia (MESH:D004415), AML (MESH:D015470), colorectal, oesophageal, pancreatic, cervical, and squamous cell carcinoma of the head and neck (MESH:D000077195), skin cancer (MESH:D012878), IBD (MESH:D015212), bleeding (MESH:D006470), breast cancer (MESH:D001943), gastric cancer (MESH:D013274), adenoma polyp (MESH:D011127), colorectal hyperplastic polyps (MESH:D003111), carcinogenesis (MESH:D063646), ovarian cancer (MESH:D010051), stroke (MESH:D020521), adenoma (MESH:D000236), Cancer (MESH:D009369), oesophageal adenocarcinoma (MESH:D000230), EAC (MESH:C536611), lung cancer (MESH:D008175), cardiovascular disease (MESH:D002318), acute lymphoblastic leukaemia (MESH:D054218), myocardial infarction (MESH:D009203), rectal cancer (MESH:D012004), EC - oesophageal carcinoma (MESH:D000077277), digestive system cancer (MESH:D004067), brain and spinal cord tumours (MESH:D013120), head and neck cancer (MESH:D006258), Wilms tumour (MESH:D009396), Barrett's oesophagus (MESH:D001471), prostate cancer (MESH:D011471), PDAC (MESH:C537768), pancreatic ductal adenocarcinoma (MESH:D021441), adenomatous polyps (MESH:D018256), pancreatic cancer (MESH:D010190), dysplasia (MESH:D015792), colon cancer (MESH:D015179), gastric precancerous condition (MESH:D011230), death (MESH:D003643)
- **Chemicals:** alcohol (MESH:D000438), FA (MESH:D005492), aspirin (MESH:D001241), homocysteine (MESH:D006710), uracil (MESH:D014498), one (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922470/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12922470/full.md

## References

98 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922470/full.md

---
Source: https://tomesphere.com/paper/PMC12922470